Collaborative development of a new fill/finish instrument

Sponsor

The lack of a robust, scalable solution for autologous cell therapy fill-finish has ensured that this vital final step in the bioprocess remains fraught with challenges. Typically, industry has been forced to resort to a suboptimal, manual syringe and manifold approach.

This webinar examine the very latest technology and its capability to deliver the commercially ready, small volume fill-finish instrument required by industry. In addition, a diverse panel offering expert drug developer, CMO/CRO and tool provider perspectives explore future partnering models and methods for accelerating the novel product development process and further advancing the cell and gene therapy industry.

Overview of a typical process for developing a new off-the-shelf instrument, including opportunities for user input
Examples of key learnings from user feedback that had important implications in the development of a new instrument designed for use in fill/finish and other wash/concentrate/formulate/aliquot applications
Importance of tool provider and customer early data generation
Tool provider and contract manufacturer perspectives on the most effective ways to collaborate during instrument development and opportunities for the field to improve